debrisoquin and Coma
debrisoquin has been researched along with Coma in 2 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Gerstenbrand, F | 1 |
Hackl, JM | 1 |
Rumpl, E | 1 |
Muldowney, FP | 1 |
Other Studies
2 other studies available for debrisoquin and Coma
Article | Year |
---|---|
[Use of a beta blocker in a traumatic apallic syndrome].
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Brain Injuries; Brain Stem; Coma; Debrisoquin; Dr | 1981 |
Management of severe hypertension.
Topics: Chlorthalidone; Coma; Debrisoquin; Diazoxide; Guanethidine; Humans; Hypertension, Malignant; Methyld | 1972 |